Tag: Cell
Breakthrough RNA therapy offers new hope for Alzheimer’s
Indian researchers uncover the miR-7a–Klf4 pathway as a promising therapeutic target, combining RNA-based treatment and a natural compound to halt brain inflammation and cell death in Alzheimer’s
Miltenyi Biotec and THSTI partner to launch India’s first hands-on CAR-T...
This groundbreaking collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies
Cell and gene therapy market set to grow at 31.3% CAGR...
Significant advancements in treatments for dermatology disorders are anticipated, driven by innovations from both small to mid-size pharma and biotech companies
DBT & BIRAC host webinar on biomanufacturing & biofoundry initiative on...
The webinar provided a platform for academia, industry leaders, start-ups, and researchers to discuss advancements, as well as, opportunities in Cell and Gene Therapy
Cell & gene therapy market set to grow at 44% CAGR...
Significant advancements in treatments for gastrointestinal (GI) disorders are anticipated, driven by innovations from both large and small pharma companies, says GlobalData
Bharat Biotech enters gene & cell therapies segment, launches India’s only...
The 50,000-square-foot dedicated state-of-the-art CGT facility represents the next milestone in BBIL’s long-standing mission to deliver targeted, life-saving treatments
First patient in India administered Bi-Specific CAR-T therapy for multiple Myeloma
A team of doctors led by acclaimed oncologist Dr Vijay Patil and including Dr Bilal Kazi, Dr Saurabh Bhave and Dr Ashay Karpe, administered the treatment here at SUNACT’s Thane centre
East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures...
The newly raised funds will be utilized to enable several key initiatives like pre-clinical testing of CAR-NK and CAR-gamma delta T cell therapies
IIT Madras releases most detailed 3D high-res images of human fetal...
For the first time in the world, 5,132 Brain sections were digitally imaged at cell-resolution using cutting-edge Brain Mapping Technology
China’s surge in antibody-drug conjugates positions it as key oncology market,...
ADCs have become a focal point in oncology due to their ability to selectively target cancer cells, resulting in reduced off-target side effects.